| Product Code: ETC8696713 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Oman Parkinsons Disease Market Overview |
3.1 Oman Country Macro Economic Indicators |
3.2 Oman Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Oman Parkinsons Disease Market - Industry Life Cycle |
3.4 Oman Parkinsons Disease Market - Porter's Five Forces |
3.5 Oman Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Oman Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Oman Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Oman Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Oman Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Oman Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about Parkinson's disease in Oman |
4.2.2 Growing elderly population in Oman |
4.2.3 Advancements in healthcare infrastructure and technology in Oman |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in remote areas of Oman |
4.3.2 High cost of Parkinson's disease medications and treatments in Oman |
5 Oman Parkinsons Disease Market Trends |
6 Oman Parkinsons Disease Market, By Types |
6.1 Oman Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Oman Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Oman Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Oman Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Oman Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Oman Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Oman Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Oman Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Oman Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Oman Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Oman Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Oman Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Oman Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Oman Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Oman Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Oman Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Oman Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Oman Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Oman Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Oman Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Oman Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Oman Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Oman Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Oman Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Oman Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Oman Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Oman Parkinsons Disease Market Export to Major Countries |
7.2 Oman Parkinsons Disease Market Imports from Major Countries |
8 Oman Parkinsons Disease Market Key Performance Indicators |
8.1 Number of new Parkinson's disease cases diagnosed annually in Oman |
8.2 Percentage increase in funding for Parkinson's disease research and treatment in Oman |
8.3 Adoption rate of new Parkinson's disease treatments and therapies in Oman |
9 Oman Parkinsons Disease Market - Opportunity Assessment |
9.1 Oman Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Oman Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Oman Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Oman Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Oman Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Oman Parkinsons Disease Market - Competitive Landscape |
10.1 Oman Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Oman Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here